Oakes Gregory 4
4 · Landos Biopharma, Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Oakes Gregory
DirectorChief Executive Officer
Transactions
- Award
Restricted Stock Unit
2024-02-29+54,454→ 54,454 totalExp: 2034-02-28→ Common Stock (54,454 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of Landos Biopharma, Inc., Inc. common stock.
- [F2]The Restricted Stock Unit ("RSU") shall vest as to 66 2/3% of the shares underlying the RSU on the second anniversary of the date of grant and shall vest as to 33 1/3% of the shares underlying the RSU on the third anniversary of the date of grant, subject to the Reporting Person's continuous service with the Issuer on each such date.